WHO team visits Wuhan Institute of Virology on COVID-19 origins investigation mission ANI | Updated: Feb 03, 2021 13:33 IST
Wuhan [China], February 3 (ANI/Sputnik): The team of experts from the World Health Organization (WHO) visited the Wuhan Institute of Virology on Wednesday, as part of their mission to investigate the origins of COVID-19, local media reported.
The WHO team visited the P4 lab inside the Wuhan Institute of Virology, the state-owned Global Times reported.
The team of WHO experts arrived in Wuhan on January 14 to investigate the origins of COVID-19, as the world s first cluster of infected patients were detected in the city in December 2019. The WHO team only began fieldwork last week, after completing two weeks of quarantine upon arrival.
Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication
January 26, 2021 08:30 ET | Source: Vaxart, Inc. Vaxart, Inc. South San Francisco, California, UNITED STATES
New pre-clinical histology data show that Vaxart’s oral vaccine protected against lung inflammation in hamster models An article published in Nature Medicine reports data from a collaboration with Stanford University researchers on in vitro activity of Vaxart’s COVID-19 vaccine
Data from Vaxart’s Phase I COVID-19 trial expected to be released next week
SOUTH SAN FRANCISCO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, announced today additional results from its SARS-CoV-2 Hamster Challenge Study, as well as a peer-reviewed publication in Nature Medicine resulting from a collaboration w
Share this article
Share this article
PALO ALTO, Calif., Feb. 2, 2021 /PRNewswire/ Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today announced that a presentation of clinical study data on its investigational therapy KSI-301 will be made at the upcoming Angiogenesis, Exudation, and Degeneration 2021 – Virtual Edition meeting.
Details of the presentation are as follows:
Title: KSI-301: Intravitreal Antibody Biopolymer Conjugate that Demonstrates Extended Durability in Wet AMD and Retinal Vascular Diseases
Presenter: Diana V. Do, M.D., Professor of Ophthalmology at Byers Eye Institute, Stanford University School of Medicine, Stanford, CA
E-Mail
IMAGE: A microscopy image of a section of a mouse colon, showing a protective layer of mucus in green that is often disrupted in human inflammatory bowel disease, or IBD. A. view more
Credit: Katharine Ng, Tropini Lab, University of British Columbia
Just like us, immune cells need fuel to do their jobs. Despite the tight links between human health including our immunity and how our bodies process what we eat, the intersection of immunology and metabolism remains a poorly understood area of human biology.
New awards announced today by The Paul G. Allen Frontiers Group, a division of the Allen Institute, aim to improve that understanding by supporting four research projects in the emerging field of immunometabolism. The projects, which are led by 10 new Allen Distinguished Investigators working in teams of two or three lead investigators per award, will explore new avenues of basic biology, health, disease, and technology development, all focused on unanswer